ICC COVID Immunization Dashboard

The recent changes in federal and state immunization policies for the 2025–2026 COVID-19 season have left many Americans uncertain about whether to get COVID-19 shots—and how to do so. To help navigate the current landscape in each state, the Immunocompromised Collaborative immunization dashboard from the Immune Deficiency Foundation tracks who is eligible for the 2025-2026 COVID-19 vaccine, as well as who can get it from a pharmacy without a prescription and whether state-regulated health insurance plans have to cover the cost.

MAPRx 2026 Open Enrollment Guide

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2025 – December 7, 2025 for coverage beginning January 1, 2026. Certain people with Medicare can also change plans at other times. Every year plans make changes to benefits and costs. With these different changes, your current plan may or may not be the best plan for you in 2026.

This guide can help find answers to some important questions that can help you during the Annual Open Enrollment.

MAPRx MPPP Patient Guide for 2026

If your prescription drug costs are high, you may benefit from participating in the Medicare Prescription Payment Plan, also known as MPPP. This guide from Medicare Access for Patients Rx describes the Medicare Prescription Payment Plan and helps patients decide if it is right for them.

HIV Prevention Resources for Black Women to Thrive

As a direct response to insights gathered from an Empower Initiative survey, HealthHIV developed a comprehensive resource guide designed to bridge the gaps in healthcare access for Black women. This guide serves as a vital tool, equipping individuals with the knowledge and support needed to navigate medical systems with confidence.

NIAID HIV Language Guide

This guide includes language suggestions for communicating about HIV and related topics.

Patients With HIV May Have High Prevalence of Long COVID

The prevalence of long COVID was high in patients living with HIV, according to a review published in eClinicalMedicine.

Recommendations for Incorporating Geriatrics Into HIV Care Include Attention to Both Body and Mind

Of the nearly 1.1 million people living with HIV in the United States in 2022, an estimated 54% were over 50 years old, according to the Centers for Disease Control and Prevention (CDC). Yet we are not doing enough to meet the needs of this population: A recent CDC study found that the country was on pace to miss all of its 2025 goals for improving the quality of life for people living with HIV age 50 and older.

Nearly 20% of New HIV Diagnoses Occur Among Older Adults

Patients aged 50 and older who were newly diagnosed with HIV often reported heterosexual transmission and were more often women when compared with those younger than 50, according to an analysis of patients in New York State that was published in JAIDS.

Resource Guide: HIV/HCV Health and Housing Collaborative

HealthHIV’s HIV/HCV Health and Housing’s 2023 Resource Guide was developed throughout a year-long technical assistance project with eight organizations working to increase their HIV/HCV screening and care capacity for their clients experiencing homelessness. The resources in this document provide insight into HIV/HCV care for people experiencing homelessness in a variety of settings and with a variety of populations.

PDAB Action Steps for Patients

Patients looking to contribute to the conversation about drug affordability and Upper Payment Limits (UPLs) can start here.

PDAB: Balancing the Scale

The Role of PDABs in Drug Pricing and Healthcare Stakeholder Impacts

Considerations and Implications of PDABs and Their Impact on 340Bs

Prescription Drug Affordability Boards (PDABs) are designed to help reduce the costs of prescription medications in 11 states where they currently exist (legislation pending in 13 more states).